Despite huge potential, the market for mobile-enabled healthcare has struggled to get off the ground. Long shackled by regulation, privacy issues and a lack of mobile standards, industry players—healthcare providers, pharmaceutical companies, insurers, governmental organizations and others—have yet to find a clear and coordinated path forward.
“There have been experiments with mobile programs,” said Victoria Petrock, eMarketer research analyst and author of the new report, “Mobile Healthcare Marketing: Prescriptions for Health and Wellness on the Go.” “But many efforts to market and deliver large-scale healthcare via mobile have, to date, been siloed and ineffectively measured.”
According to a survey of mobile health developers and marketers around the world by research2guidance, smartphones hold the key to mobile health business opportunities over the next several years, followed closely by tablets. Adoption of both is rising quickly, making the landscape ripe for m-health opportunities.
Pew Internet & American Life Project found that specific demographic groups were more apt to use m-health resources. More men than women used apps to track their health. Black and Hispanic consumers, those who lived in urban areas, and adults ages 18 to 29 also showed higher-than-average use of the mobile web and apps for healthcare.
“Mobile is giving consumers the control to help them better manage chronic diseases,” said Petrock. “As they embrace mobile devices and platforms to find and share information and monitor bio-data, more consumers are taking charge of their personal health and wellness. This presents an opportunity for marketers to encourage healthier behaviors and personalize the delivery of healthcare information and services.”
The full report, “Mobile Healthcare Marketing: Prescriptions for Health and Wellness on the Go” also answers these key questions:
To purchase the report, click here. Total Access clients, log in and view the report now.
Check out today’s other article, “Facebook Dominant Social Network for SMBs.”
You've never experienced research like this.
Nearly all Fortune 500 companies rely on us.
Inquire about corporate subscriptions today.